Moss Adams Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Moss Adams Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$617K	Buy	4,880 +23	+0.5%	+$3.03K	0.04%	132
2026 Q1	$677K	Buy	4,857 +411	+9%	+$57.6K	0.05%	114
2025 Q4	$546K	Buy	4,446 +76	+2%	+$9.24K	0.04%	123
2025 Q3	$485K	Buy	4,370 +172	+4%	+$19.6K	0.04%	131
2025 Q2	$465K	Buy	4,198 +498	+13%	+$53K	0.04%	135
2025 Q1	$415K	Buy	3,700 +586	+19%	+$60.5K	0.04%	127
2024 Q4	$288K	Buy	3,114 +555	+22%	+$50K	0.03%	151
2024 Q3	$215K	Buy	+2,559	New	+$195K	0.02%	187

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Moss Adams Wealth Advisors's GILD Position: Q2 2026 in Review

Moss Adams Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.47% in Q2 2026, buying an estimated $3.03K and bringing the position to 4,880 shares worth $617K. The position accounts for 0.04% of the portfolio, ranked #132.

Moss Adams Wealth Advisors first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $677K in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Moss Adams Wealth Advisors held 4,880 shares of Gilead Sciences worth $617K as of Q2 2026.
Moss Adams Wealth Advisors bought 23 Gilead Sciences shares in Q2 2026, an estimated $3.03K.
Gilead Sciences made up 0.04% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #132 holding.
Moss Adams Wealth Advisors first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
Moss Adams Wealth Advisors's Gilead Sciences position peaked at $677K in Q1 2026.
2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.